Clinical and histopathological study of actinic keratosis treatment with photodynamic therapy VS 5-fluorouracil for face cancerization

Actinic keratosis (AK) is one of the most frequent pathologies in clinical dermatology. Approximately 10% of the prevalence of AK occurs at 30 years of age and rises to 80% at 70 years of life. This study conducted a split-face analysis based on Photodynamic Therapy (MALA-PDT) and 5-fluorouracil (5-FU) treatments in patients with AK. Clinical and histopathological studies evaluated each treatment's efficiency and side effects. Six patients were recruited between 50 and 70 years of age for this. MALA-PDT was applied on the right side of the face. A biodistribution time of 2 h, a dose of light of 36 J/cm2 (20 min irradiation), a spot for photoirradiation with a total area of 100 cm2, and a wavelength of 635 nm were used. (LINCE equipment MMOPTICS-Brazil). By fluorescence diagnosis, clinical and subclinical AK lesions were evidenced in the area called the cancerization field. Two cycles of MALA-PDT were performed on each patient, and 5-FU was applied twice daily for 15 days. A 2-month follow-up post-MALA-PDT and post-5-FU was carried out. The treatment based on 5-Flu and MALA-PDT clinically shows the same response, but MALA-PDT is less aggressive than 5-FU. The treatment of AK based on MALAPDT is a practical, inexpensive, and easy-to-use technique.

Automated summary

This study compared the efficacy and side effects of Photodynamic Therapy (MALA-PDT) and 5-fluorouracil (5-FU) treatments for actinic keratosis (AK). The results showed that MALA-PDT was less aggressive than 5-FU but had the same clinical response. MALA-PDT-based treatment for AK is a practical, inexpensive, and easy-to-use technique.